$35.92
0.050.14%
Pre-Market: 6:00 PM EDT
15 minutes delayed
Comments
Loading...
Exelon
EXCNASDAQ
Exelon (NASDAQ:EXC) Stock, Analyst Ratings, Price Targets, Forecasts
Exelon Corp has a consensus price target of $42.95 based on the ratings of 22 analysts. The high is $69 issued by Morgan Stanley on December 17, 2021. The low is $36 issued by Barclays on January 22, 2024. The 3 most-recent analyst ratings were released by Barclays, Morgan Stanley, and Morgan Stanley on July 22, 2024, June 24, 2024, and May 28, 2024, respectively. With an average price target of $40.33 between Barclays, Morgan Stanley, and Morgan Stanley, there's an implied 12.29% upside for Exelon Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Morgan Stanley
Wells Fargo
BMO Capital
Scotiabank
1calculated from analyst ratings
Analyst Ratings for Exelon
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/22/2024 | Buy Now | 14.14% | Barclays | Nicholas Campanella | $39 → $41 | Maintains | Overweight | Get Alert |
| 06/24/2024 | Buy Now | 8.57% | Morgan Stanley | David Arcaro | $41 → $39 | Maintains | Equal-Weight | Get Alert |
| 05/28/2024 | Buy Now | 14.14% | Morgan Stanley | David Arcaro | $38 → $41 | Maintains | Equal-Weight | Get Alert |
| 05/03/2024 | Buy Now | 11.36% | Wells Fargo | Neil Kalton | $39 → $40 | Maintains | Equal-Weight | Get Alert |
| 05/03/2024 | Buy Now | 16.93% | BMO Capital | James Thalacker | $40 → $42 | Maintains | Outperform | Get Alert |
| 04/22/2024 | Buy Now | 3.01% | Scotiabank | Andrew Weisel | $39 → $37 | Maintains | Sector Perform | Get Alert |
| 03/14/2024 | Buy Now | 8.57% | Barclays | Nicholas Campanella | $36 → $39 | Maintains | Overweight | Get Alert |
| 02/22/2024 | Buy Now | 8.57% | Wells Fargo | Neil Kalton | $41 → $39 | Maintains | Equal-Weight | Get Alert |
| 01/22/2024 | Buy Now | 0.22% | Barclays | Eric Beaumont | $38 → $36 | Maintains | Overweight | Get Alert |
| 01/19/2024 | Buy Now | 0.22% | B of A Securities | Paul Zimbardo | $38 → $36 | Maintains | Neutral | Get Alert |
| 01/10/2024 | Buy Now | 8.57% | Mizuho | Paul Fremont | $36 → $39 | Upgrade | Neutral → Buy | Get Alert |
| 01/08/2024 | Buy Now | — | Seaport Global | Angie Storozynski | — | Downgrade | Buy → Neutral | Get Alert |
| 01/02/2024 | Buy Now | 3.01% | UBS | Daniel Ford | $47 → $37 | Downgrade | Buy → Neutral | Get Alert |
| 12/19/2023 | Buy Now | 5.79% | RBC Capital | Shelby Tucker | $45 → $38 | Maintains | Sector Perform | Get Alert |
| 12/18/2023 | Buy Now | 0.22% | Mizuho | Paul Fremont | $40 → $36 | Maintains | Neutral | Get Alert |
| 12/18/2023 | Buy Now | 5.79% | Morgan Stanley | David Arcaro | $45 → $38 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/15/2023 | Buy Now | — | Evercore ISI Group | Durgesh Chopra | — | Downgrade | Outperform → In-Line | Get Alert |
| 12/15/2023 | Buy Now | 11.36% | Guggenheim | Shahriar Pourreza | → $40 | Downgrade | Buy → Neutral | Get Alert |
| 11/21/2023 | Buy Now | 19.71% | Morgan Stanley | Stephen Byrd | $42 → $43 | Maintains | Overweight | Get Alert |
| 11/21/2023 | Buy Now | 11.36% | Mizuho | Paul Fremont | → $40 | Downgrade | Buy → Neutral | Get Alert |
| 10/25/2023 | Buy Now | 16.93% | Morgan Stanley | Stephen Byrd | $45 → $42 | Maintains | Overweight | Get Alert |
| 10/24/2023 | Buy Now | 14.14% | Barclays | Eric Beaumont | $43 → $41 | Maintains | Overweight | Get Alert |
| 09/21/2023 | Buy Now | 25.28% | Morgan Stanley | Stephen Byrd | $44 → $45 | Maintains | Overweight | Get Alert |
| 09/06/2023 | Buy Now | 25.28% | RBC Capital | Shelby Tucker | $47 → $45 | Maintains | Sector Perform | Get Alert |
| 08/23/2023 | Buy Now | 22.49% | Morgan Stanley | Stephen Byrd | $47 → $40 | Maintains | Overweight | Get Alert |
| 08/23/2023 | Buy Now | 19.71% | Barclays | Eric Beaumont | → $43 | Initiates | → Overweight | Get Alert |
| 07/21/2023 | Buy Now | 30.85% | Morgan Stanley | David Arcaro | $47 → $47 | Reiterates | Overweight → Overweight | Get Alert |
| 07/07/2023 | Buy Now | — | Guggenheim | Shahriar Pourreza | — | Upgrade | Neutral → Buy | Get Alert |
| 06/23/2023 | Buy Now | 30.85% | Morgan Stanley | David Arcaro | $48 → $47 | Maintains | Overweight | Get Alert |
| 06/08/2023 | Buy Now | 8.57% | Goldman Sachs | Michael Lapides | → $39 | Initiates | → Sell | Get Alert |
| 06/07/2023 | Buy Now | 28.06% | JP Morgan | Jeremy Tonet | $50 → $46 | Maintains | Overweight | Get Alert |
| 05/25/2023 | Buy Now | 22.49% | BMO Capital | James Thalacker | $46 → $44 | Maintains | Outperform | Get Alert |
| 05/22/2023 | Buy Now | 33.63% | Morgan Stanley | David Arcaro | $49 → $48 | Maintains | Overweight | Get Alert |
| 05/16/2023 | Buy Now | 25.28% | Mizuho | Paul Fremont | $46 → $45 | Maintains | Buy | Get Alert |
| 04/20/2023 | Buy Now | 36.41% | Morgan Stanley | David Arcaro | $46 → $49 | Maintains | Overweight | Get Alert |
| 03/21/2023 | Buy Now | 28.06% | Morgan Stanley | David Arcaro | $49 → $46 | Maintains | Overweight | Get Alert |
| 02/15/2023 | Buy Now | 25.28% | BMO Capital | James Thalacker | $46 → $45 | Maintains | Outperform | Get Alert |
| 01/23/2023 | Buy Now | 28.06% | Credit Suisse | Nicholas Campanella | $42 → $46 | Maintains | Outperform | Get Alert |
| 01/09/2023 | Buy Now | 28.06% | Mizuho | Paul Fremont | $39 → $46 | Maintains | Buy | Get Alert |
| 12/15/2022 | Buy Now | 36.41% | Morgan Stanley | Stephen Byrd | $46 → $49 | Maintains | Overweight | Get Alert |
| 11/11/2022 | Buy Now | 28.06% | Morgan Stanley | Stephen Byrd | $43 → $46 | Maintains | Overweight | Get Alert |
| 11/04/2022 | Buy Now | 8.57% | Mizuho | Paul Fremont | $47 → $39 | Maintains | Buy | Get Alert |
| 10/21/2022 | Buy Now | 19.71% | Morgan Stanley | Stephen Byrd | $52 → $43 | Maintains | Overweight | Get Alert |
| 10/20/2022 | Buy Now | — | Keybanc | Sophie Karp | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 10/19/2022 | Buy Now | 16.93% | Wells Fargo | Neil Kalton | $49 → $42 | Maintains | Equal-Weight | Get Alert |
| 10/19/2022 | Buy Now | 8.57% | Credit Suisse | Nicholas Campanella | $43 → $39 | Initiates | → Outperform | Get Alert |
| 10/18/2022 | Buy Now | 14.14% | BMO Capital | James Thalacker | $51 → $41 | Maintains | Outperform | Get Alert |
| 10/03/2022 | Buy Now | 19.71% | Credit Suisse | Nicholas Campanella | → $43 | Initiates | → Outperform | Get Alert |
| 09/22/2022 | Buy Now | 44.77% | Morgan Stanley | Stephen Byrd | $54 → $52 | Maintains | Overweight | Get Alert |
| 08/31/2022 | Buy Now | 30.85% | Mizuho | Paul Fremont | $46 → $47 | Maintains | Buy | Get Alert |
| 08/23/2022 | Buy Now | 50.33% | Morgan Stanley | Stephen Byrd | $50 → $54 | Maintains | Overweight | Get Alert |
| 08/04/2022 | Buy Now | 41.98% | BMO Capital | James Thalacker | $49 → $51 | Maintains | Outperform | Get Alert |
| 08/04/2022 | Buy Now | 36.41% | Wells Fargo | Neil Kalton | $52 → $49 | Maintains | Equal-Weight | Get Alert |
| 07/21/2022 | Buy Now | 39.2% | Morgan Stanley | Stephen Byrd | $46 → $50 | Maintains | Overweight | Get Alert |
| 07/19/2022 | Buy Now | 25.28% | Keybanc | Sophie Karp | $53 → $45 | Maintains | Overweight | Get Alert |
| 07/18/2022 | Buy Now | 28.06% | Barclays | Eric Beaumont | $50 → $46 | Maintains | Equal-Weight | Get Alert |
| 06/30/2022 | Buy Now | 36.41% | UBS | Ross Fowler | $54 → $49 | Maintains | Buy | Get Alert |
| 06/08/2022 | Buy Now | 50.33% | Argus Research | Jacob Kilstein | $50 → $54 | Maintains | Buy | Get Alert |
| 05/23/2022 | Buy Now | 44.77% | Morgan Stanley | Stephen Byrd | $54 → $52 | Maintains | Overweight | Get Alert |
| 05/10/2022 | Buy Now | 39.2% | Wells Fargo | Neil Kalton | $52 → $50 | Maintains | Equal-Weight | Get Alert |
| 04/27/2022 | Buy Now | 44.77% | Wells Fargo | Neil Kalton | $45 → $52 | Maintains | Equal-Weight | Get Alert |
| 04/20/2022 | Buy Now | 50.33% | Morgan Stanley | Stephen Byrd | $50 → $54 | Maintains | Overweight | Get Alert |
| 04/20/2022 | Buy Now | 53.12% | JP Morgan | Jeremy Tonet | → $55 | Upgrade | Neutral → Overweight | Get Alert |
| 04/20/2022 | Buy Now | 47.55% | Keybanc | Sophie Karp | $51 → $53 | Maintains | Overweight | Get Alert |
| 04/07/2022 | Buy Now | 41.98% | Keybanc | Sophie Karp | $49 → $51 | Maintains | Overweight | Get Alert |
| 03/22/2022 | Buy Now | 39.2% | Morgan Stanley | Stephen Byrd | $47 → $50 | Maintains | Overweight | Get Alert |
| 03/11/2022 | Buy Now | 28.06% | Mizuho | Paul Fremont | $43 → $46 | Upgrade | Neutral → Buy | Get Alert |
| 02/07/2022 | Buy Now | 22.49% | Scotiabank | Andrew Weisel | $55 → $44 | Downgrade | Sector Outperform → Sector Perform | Get Alert |
| 02/04/2022 | Buy Now | 22.49% | Goldman Sachs | Michael Lapides | $62 → $44 | Downgrade | Buy → Neutral | Get Alert |
| 02/03/2022 | Buy Now | 19.71% | Mizuho | Paul Fremont | $57 → $43 | Maintains | Neutral | Get Alert |
| 02/03/2022 | Buy Now | 36.41% | Morgan Stanley | Stephen Byrd | $74 → $49 | Maintains | Overweight | Get Alert |
| 02/03/2022 | Buy Now | 25.28% | Wells Fargo | Neil Kalton | → $45 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/03/2022 | Buy Now | 28.06% | RBC Capital | Shelby Tucker | $66 → $46 | Downgrade | Outperform → Sector Perform | Get Alert |
| 02/03/2022 | Buy Now | 25.28% | Vertical Research | Jonathan Arnold | → $45 | Downgrade | Buy → Hold | Get Alert |
| 01/13/2022 | Buy Now | 89.31% | Keybanc | Sophie Karp | → $68 | Upgrade | Sector Weight → Overweight | Get Alert |
| 01/11/2022 | Buy Now | 106.01% | Morgan Stanley | Stephen Byrd | $69 → $74 | Maintains | Overweight | Get Alert |
| 01/03/2022 | Buy Now | 58.69% | Mizuho | Paul Fremont | $55 → $57 | Downgrade | Buy → Neutral | Get Alert |
| 12/17/2021 | Buy Now | 92.09% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 11/22/2021 | Buy Now | 100.45% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 10/15/2021 | Buy Now | 53.12% | Mizuho | Paul Fremont | $53 → $55 | Maintains | Buy | Get Alert |
| 10/12/2021 | Buy Now | 72.61% | Wells Fargo | Neil Kalton | — | Maintains | Overweight | Get Alert |
| 09/14/2021 | Buy Now | 47.55% | Mizuho | Paul Fremont | — | Upgrade | Neutral → Buy | Get Alert |
| 09/13/2021 | Buy Now | 53.12% | BMO Capital | James Thalacker | — | Maintains | Outperform | Get Alert |
| 08/19/2021 | Buy Now | 83.74% | Morgan Stanley | Stephen Byrd | — | Maintains | Overweight | Get Alert |
| 08/12/2021 | Buy Now | — | Mizuho | Paul Fremont | — | Upgrade | Underperform → Neutral | Get Alert |
FAQ
What is the target price for Exelon (EXC) stock?
The latest price target for Exelon (NASDAQ:EXC) was reported by Barclays on July 22, 2024. The analyst firm set a price target for $41.00 expecting EXC to rise to within 12 months (a possible 14.14% upside). 26 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Exelon (EXC)?
The latest analyst rating for Exelon (NASDAQ:EXC) was provided by Barclays, and Exelon maintained their overweight rating.
When was the last upgrade for Exelon (EXC)?
The last upgrade for Exelon Corp happened on January 10, 2024 when Mizuho raised their price target to $39. Mizuho previously had a neutral for Exelon Corp.
When was the last downgrade for Exelon (EXC)?
The last downgrade for Exelon Corp happened on January 8, 2024 when Seaport Global changed their price target from N/A to N/A for Exelon Corp.
When is the next analyst rating going to be posted or updated for Exelon (EXC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exelon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exelon was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.
Is the Analyst Rating Exelon (EXC) correct?
While ratings are subjective and will change, the latest Exelon (EXC) rating was a maintained with a price target of $39.00 to $41.00. The current price Exelon (EXC) is trading at is $35.92, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.